Canbi  Pharma  Tech  Txwv tsis pub
1513883-39-0} kev ua kom tsis muaj sia ruuteriib

1513883-39-0} kev ua kom tsis muaj sia ruuteriib

Khoom npe: Kev ua txhaum RuXolitinib
CAS: 1513883-39-0
Mf: c17h18n6
MW: 306.37
Einecs:
MDL tsis muaj .:

Xa kev nug
Hauj lwm lawm

Cov Khoom Siv
Cov tsos dawb rau-dawb hmoov

 

Daim Ntawv Thov:

Kev siv lub ntsiab ntawm deuruxolitinib yog kho alopecia {}}}} Ua rau cov txheej txheem Jak1
 

Cov lus txhais lus:

Deuruxolitinib

Ctp -543

(3R) -3- (2,2,3,4,5, {{} use oct} {}} [{{} (7 H-Pyrrolo [2, 3- d] Pyrimidin {{16}-1- yl] propanenitrile

1H-pyrazole -1-} propanenitrile, . Beta.- ({{{{} {{} d) pyrimidin-4- yl) -, (. beta . r) -

1513883-39-0

Deuruxolitinib-D8

(3R) -3- (2,2,3,4,5, {} d8) Cyclopentyl {}} ({} (7h-pyrrol o (2, 3- d) Pyrimidin {}} hp) {{{{19} {xyoo 19} € yl) propanenitrile

 

Cim npe nrov: 1513883-39-0} Kev ua tsis tau zoo ruexolitinib, Tuam Tshoj {{{}}} Douterated Rupolitinib tuam ntxhab, lwm tus neeg

Inquiry
goTop

(0/10)

clearall